Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

BACKGROUND: Results from large randomised controlled trials combining docetaxel or bisphosphonates with standard of care in hormone-sensitive prostate cancer have emerged. In order to investigate the effects of these therapies and to respond to emerging evidence, we aimed to systematically review al...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Lancet Oncol
मुख्य लेखकों: Vale, Claire L, Burdett, Sarah, Rydzewska, Larysa H M, Albiges, Laurence, Clarke, Noel W, Fisher, David, Fizazi, Karim, Gravis, Gwenaelle, James, Nicholas D, Mason, Malcolm D, Parmar, Mahesh K B, Sweeney, Christopher J, Sydes, Matthew R, Tombal, Bertrand, Tierney, Jayne F
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Lancet Pub. Group 2016
विषय:
Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737894/
https://ncbi.nlm.nih.gov/pubmed/26718929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(15)00489-1
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन